Product Portfolio

The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.

RX

- Prescription Medicines

Medicines available by medical prescription only.

INDOMETACIN ARENA 50 mg

Non-steroidal anti-inflammatory drug with strong action, indicated in arthritis, gout and rheumatic conditions

Capsules

50 mg

See details

IZONIAZIDA ARENA 100 mg

Essential antituberculosis drug, first-line in the treatment of tuberculosis

Tablets

100 mg

See details

IZONIAZIDA ARENA 300 mg

Essential antituberculosis drug, first-line in the treatment of tuberculosis

Tablets

300 mg

See details

LEFUNOMIDA ARENA 10 mg

Immunomodulatory drug indicated in the treatment of active rheumatoid arthritis

Film-coated tablets

10 mg

See details

LEFUNOMIDA ARENA 100 mg

Immunomodulatory drug indicated in the treatment of active rheumatoid arthritis

Film-coated tablets

100 mg

See details

LEFUNOMIDA ARENA 20 mg

Immunomodulatory drug indicated in the treatment of active rheumatoid arthritis

Film-coated tablets

20 mg

See details

LEVETIRACETAM ARENA 1000 mg

New-generation anticonvulsant indicated in the treatment of epilepsy

Film-coated tablets

1000 mg

See details

LEVETIRACETAM ARENA 500 mg

New-generation anticonvulsant indicated in the treatment of epilepsy

Film-coated tablets

500 mg

See details

LEVOFLOXACINA ARENA 250 mg

Fluoroquinolone antibiotic, indicated in respiratory and urinary tract infections

Film-coated tablets

250 mg

See details